Agilex expands bioanalytical labs capacity to meet US, APAC demand

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/marchmeena29)
(Image: Getty/marchmeena29)

Related tags: expansion, facility, Australia, Bioanalytical

Agilex has expanded its bioanalytical laboratories by 30%, in order to accommodate demand coming mainly from US and APAC-based biotech companies.

Australia-based Agilex Biolabs is a contract research organization (CRO) providing bioanalytical services for researchers at early stages of clinical development, supporting clients in Asia, Europe and the US.

Per its services, the company focuses on bioanalysis for small molecules and biologics for pharmacokinetics, immunogenicity and biomarkers, utilizing two platforms that conduct liquid chromatography, mass spectrometry, and immunoassays.

The expansion will see Agilex’s facilities located in a biotech hub in Adelaide, South Australia grow by 30%, enabling the company to include a range of additional pharmacodynamics services​ in its offering.

According to the company, the Adelaide laboratory is the only FDA-inspected facility of its type in the region.

Agilex’s CEO, Jason Valentine, said that the facility employs more than 65 dedicated laboratory staff, working to support more than 80 clinical trials every year.

“This year we will analyze more than 60,000 samples for pharma and biotechs from the US, Europe and APAC,”​ said Valentine, adding that, to date, the company has supported hundreds of preclinical and clinical trials around the world.

Amid the ongoing coronavirus pandemic, the company announced that it will be offering virtual tours in the expanded laboratories.

Related news

Show more

Related products

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more